- Home
- ZS vs IDXX Comparison
ZS vs IDXX Comparison
Compare ZS & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZS
- IDXX
- Stock Information
- Founded
- ZS 2007
- IDXX 1983
- Country
- ZS United States
- IDXX United States
- Employees
- ZS N/A
- IDXX N/A
- Industry
- ZS EDP Services
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ZS Technology
- IDXX Health Care
- Exchange
- ZS Nasdaq
- IDXX Nasdaq
- Market Cap
- ZS 45.0B
- IDXX 42.7B
- IPO Year
- ZS 2018
- IDXX 1991
- Fundamental
- Price
- ZS $272.52
- IDXX $645.55
- Analyst Decision
- ZS Buy
- IDXX Buy
- Analyst Count
- ZS 34
- IDXX 7
- Target Price
- ZS $296.73
- IDXX $610.71
- AVG Volume (30 Days)
- ZS 1.4M
- IDXX 785.2K
- Earning Date
- ZS 09-02-2025
- IDXX 08-04-2025
- Dividend Yield
- ZS N/A
- IDXX N/A
- EPS Growth
- ZS N/A
- IDXX 19.17
- EPS
- ZS N/A
- IDXX 12.01
- Revenue
- ZS $2,546,757,000.00
- IDXX $4,037,715,000.00
- Revenue This Year
- ZS $26.35
- IDXX $10.76
- Revenue Next Year
- ZS $20.48
- IDXX $8.15
- P/E Ratio
- ZS N/A
- IDXX $53.64
- Revenue Growth
- ZS 25.46
- IDXX 6.68
- 52 Week Low
- ZS $153.45
- IDXX $356.14
- 52 Week High
- ZS $318.46
- IDXX $688.12
- Technical
- Relative Strength Index (RSI)
- ZS 41.95
- IDXX 60.67
- Support Level
- ZS $268.78
- IDXX $632.57
- Resistance Level
- ZS $282.55
- IDXX $665.03
- Average True Range (ATR)
- ZS 7.76
- IDXX 15.55
- MACD
- ZS -0.08
- IDXX -3.19
- Stochastic Oscillator
- ZS 26.34
- IDXX 39.87
About ZS Zscaler Inc.
Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.